Abian O, Ortega-alarcon D, Jimenez-alesanco A, Ceballos-laita L. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening Olga. Int J Biol Macromol Elsevier. 2020;164:1693–703.

Article  CAS  Google Scholar 

Adhikari B, Marasini BP, Rayamajhee B, Bhattarai BR, Lamichhane G, Khadayat K, Adhikari A, Khanal S, Parajuli N. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: a review. Phyther Res. 2020;35:1298–312.

Article  Google Scholar 

Bhowmik D, Nandi R, Jagadeesan R, Kumar N, Prakash A. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking-based virtual screening, and pharmacokinetics approaches. Infect Genet Evol. 2020;84:104451.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colunga Biancatelli RML, Berrill M, Catravas JD, Marik PE. Quercetin and vitamin C: an experimental, synergistic therapy for the Prevention and Treatment of SARS-CoV-2 related disease (COVID-19). Front Immunol. 2020;11:1–11.

Article  Google Scholar 

Fu L, Ye F, Feng Y, Yu F, Wang Q, Wu Y, Zhao C, Sun H, Huang B, Niu P, Song H, Shi Y, Li X, Tan W, Qi J, Gao GF. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nat Commun. 2020;11:1–8.

Article  Google Scholar 

Ge X, Liao J. Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019. Chin J Nat Med. 2020;18:61–71.

Google Scholar 

Ghosh R, Chakraborty A, Biswas A, Chowdhuri S. Evaluation of green tea polyphenols as novel coronavirus (SARS CoV-2) main protease (Mpro) inhibitors–an in silico docking and molecular dynamics simulation study. J Biomol Struct Dyn. 2020;39:4362–4374.

Article  PubMed  Google Scholar 

Ibrahim MAA, Mohamed EAR, Abdelrahman AHM. Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: in silico drug discovery study Mahmoud. J Mol Graph Model. 2021;105:107904.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Istifli ES, Netz PA, Sihoglu Tepe A, Husunet MT, Sarikurkcu C, Tepe B. In silico analysis of the interactions of certain flavonoids with the receptor-binding domain of 2019 novel coronavirus and cellular proteases and their pharmacokinetic properties. J Biomol Struct Dyn. 2020;0:1–15.

Google Scholar 

Jo S, Kim S, Kim DY, Kim MS, Shin DH. Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro. J Enzyme Inhib Med Chem. 2020;35:1539–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joshi T, Joshi T, Sharma P, Mathpal S, Pundir H, Bhatt V, Chandra S. In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking. Eur Rev Med Pharmacol Sci. 2020;24:4529–36.

CAS  PubMed  Google Scholar 

Kapusta K, Kar S, Collins JT, Franklin LM, Kolodziejczyk W, Leszczynski J, Hill GA. Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (Mpro) through docking, molecular mechanic & dynamic, and ADMET profiling. J Biomol Struct Dyn. 2020;0:1–18.

Google Scholar 

Maiti S, Banerjee A. Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study. Drug Dev Res. 2021;82:86–96.

Article  CAS  PubMed  Google Scholar 

Majumder R, Mandal M. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an in silico docking and molecular dynamics simulation approach. J Biomol Struct Dyn. 2020;0:1–16.

Google Scholar 

Menegazzi M, Campagnari R, Bertoldi M, Crupi R, Di Paola R, Cuzzocrea S. Protective effect of epigallocatechin-3-gallate (EGCG) in diseases with uncontrolled immune activation: Could such a scenario be helpful to counteract COVID-19? Int J Mol Sci. 2020;21:1–20.

Article  Google Scholar 

Mouffouk C, Mouffouk S, Mouffouk S, Hambaba L, Haba H. Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2). Eur J Pharmacol. 2021;891:173759.

Article  CAS  PubMed  Google Scholar 

Mukherjee S, Paul S. In-silico study identifies RO 28-2653 as a novel drug against SARS-CoV2 mutant strains. Int J Comput Biol Drug Des. 2021;14(6):457–80.

Article  Google Scholar 

Pal A, Pyne N, Paul S. In-silico designing of a multi-epitope vaccine against SARS-CoV-2 and studying the interaction of the vaccine with alpha, beta, delta, and omicron variants of concern. Curr Drug Discov Technol. 2022;20:67–88.

Google Scholar 

Pan B, Fang S, Zhang J, Pan Y, Liu H, Wang Y, Li M, Liu L. Chinese herbal compounds against SARS-CoV-2: puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor. Comput Struct Biotechnol J. 2020;18:3518–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pandey AK, Verma S. An in-silico evaluation of dietary components for structural inhibition of SARS-Cov-2 main protease. J Biomol Struct Dyn. 2020;0:1–7.

Google Scholar 

Pastor N, Collado MC, Manzoni P. Phytonutrient and nutraceutical action against COVID-19: current review of characteristics and benefits. Nutrients. 2021;13:1–10.

Article  Google Scholar 

Paul D, Pyne N, Paul S. Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2. VirusDis. 2021;32:703–26.

Article  CAS  Google Scholar 

Pyne N, Paul S. Screening of medicinal plants unraveled the leishmanicidal credibility of Garcinia cowa, highlighting norcowanin, a novel anti-leishmanial phytochemical through in-silico study. J Parasit Dis. 2021;46(1):202–14.

Article  PubMed  PubMed Central  Google Scholar 

Rameshkumar MR, Indu P, Arunagirinathan N, Venkatadri B, El-Serehy HA, Ahmad A. Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: a molecular docking study. Saudi J Biol Sci. 2021;28:448–58.

Article  CAS  PubMed  Google Scholar 

Russo M, Moccia S, Spagnuolo C, Tedesco I, Russo GL. Roles of flavonoids against coronavirus infection. Chem Interact. 2020;328:109211.

Article  CAS  Google Scholar 

Solnier J, Fladerer JP, Flavonoids. A complementary approach to conventional therapy of COVID-19? Phytochem Rev. 2020;20:773.

Article  PubMed  PubMed Central  Google Scholar 

Tahir ul Qamar M, Alqahtani SM, Alamri MA, Chen LL. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. 2020;10:313–9.

Article  PubMed  PubMed Central  Google Scholar 

Vijayakumar BG, Ramesh D, Joji A, Jayachandra prakasan J, Kannan T. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2. Eur J Pharmacol. 2020;886:173448.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Williamson G, Kerimi A. Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction. Biochem Pharmacol. 2020;178:114123.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zakaryan H, Arabyan E, Oo A, Zandi K. Flavonoids: promising natural compounds against viral infections. Arch Virol. 2017;162:2539–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu Y, Xie DY. Docking characterization and in vitro inhibitory activity of Flavan-3-ols and dimeric proanthocyanidins against the main protease activity of SARS-Cov-2. Front Plant Sci. 2020;11:1–14.

Article  Google Scholar